Performance analysis of Can-Fite Biopharma (CANF)
Annual Return
Over the past 3 years, CANF has had an average annual return of -61.55%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CANF has had an average annual return of -62.31%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, CANF has had an average annual return of -54.91%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 6, 2012, CANF has had an average annual return of -46.60%, underperforming the benchmark SPY, which returned +15.07% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -90.00% | -25.93% | -64.47% | -52.80% | -27.15% | -46.23% | -82.53% | -14.84% | -37.82% | -18.50% | -16.58% |
| 2014 | 2013 | 2012 | |||||||||
| -41.76% | +30.17% | -13.82% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +50% | -33.33% | +0% | +0% | +0% | +0% | ||||||
| 2025 | -10.00% | +22.22% | -18.18% | -22.22% | -7.14% | -0% | -38.46% | +0% | +0% | -37.50% | -20.00% | -50.00% | -90.00% |
| 2024 | -3.70% | +3.85% | +3.70% | -7.14% | +11.54% | +10.34% | +25% | -30.00% | -10.71% | +8% | -0% | -25.93% | -25.93% |
| 2023 | -31.58% | -34.62% | -17.65% | -21.43% | +45.45% | +18.75% | -0% | -2.63% | -10.81% | -24.24% | +16% | -6.90% | -64.47% |
| 2022 | -9.32% | +0.68% | +4.76% | -24.68% | +0.86% | -2.56% | -9.65% | +13.59% | -17.95% | +13.54% | -4.59% | -26.92% | -52.80% |
| 2021 | +10.86% | +3.67% | +20.87% | -12.05% | -0.37% | +5.58% | -12.32% | -7.23% | -10.39% | -8.70% | -21.16% | +8.05% | -27.15% |
| 2020 | -34.79% | -41.79% | +4.49% | +38.65% | +18.58% | -8.21% | +21.95% | -7.67% | -20.58% | -2.27% | +9.77% | -6.36% | -46.23% |
| 2019 | -4.76% | -3.35% | -24.11% | -39.81% | -61.38% | -6.28% | +0% | -14.80% | -16.07% | +17.58% | +46.18% | -6.59% | -82.53% |
| 2018 | +60.83% | -21.00% | -23.40% | -7.66% | -3.75% | -7.83% | -0.82% | +9.39% | +0.80% | -4.65% | +8.10% | -5.24% | -14.84% |
| 2017 | -24.79% | +8.95% | -2.06% | -1.04% | -6.35% | +1.12% | -1.11% | -5.66% | +1.19% | -7.67% | -7.69% | +2.75% | -37.82% |
Drawdown analysis of Can-Fite Biopharma (CANF)
The maximum drawdown for the CANF was -99.99%, occurring on Dec 24, 2025. This drawdown has not yet recovered.
The current CANF drawdown is -99.99%.
Since Nov 6, 2012 CANF has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Dec 23, 2013 | 3019 | Dec 24, 2025 | Ongoing | Ongoing | Ongoing |
| -40.00% | Nov 6, 2012 | 211 | Sep 10, 2013 | 15 | Oct 1, 2013 | 226 |
| -20.12% | Oct 18, 2013 | 8 | Oct 30, 2013 | 13 | Nov 18, 2013 | 21 |
| -19.97% | Nov 18, 2013 | 9 | Dec 2, 2013 | 15 | Dec 23, 2013 | 24 |
| -14.07% | Oct 2, 2013 | 5 | Oct 9, 2013 | 6 | Oct 17, 2013 | 11 |